Table 2 Demographic and clinical data of the with the patients recurrent uveitis
From: New onset or recurrence of uveitis following COVID-19 infection
Patient number (age/sex/eye) | Time from COVID-19 diagnosis to uveitis (day) | Etiology | Clinical examination on admission | Treatment | Duration of follow up (day) | Outcome at last follow-up | ||
|---|---|---|---|---|---|---|---|---|
BCVA | IOP | BCVA | IOP | |||||
Adult patient | ||||||||
Patient 10 (53/F/OU) | 20 | Vogt-Koyanagi-Harada disease | 0.3, 0.25 | 13.6, 11.5 | Topical Steroids Peribulbar methylprednisolone injection Oral Steroids, Ciclosporin | 58 | 0.4, 0.5 | 14.5, 13.4 |
Patient 11 (59/M/OU) | 21 | Vogt-Koyanagi-Harada disease | 0.2, 0.2 | 14.6, 17.1 | Topical Steroids Peribulbar methylprednisolone injection Oral Steroids | 66 | 0.8, 0.8 | 17.6, 17.5 |
Patient 12 (54/M/OU) | 7 | Vogt-Koyanagi-Harada disease | 0.1, 0.1 | 17.9, 21.8 | Topical Steroids Peribulbar methylprednisolone injection Oral Steroids, Ciclosporin | 54 | 0.1, 0.2 | 13.1, 12.8 |
Patient 13 (33/M/OU) | 5 | Anterior Uveitis | 0.6, 0.7 | 12.9, 13.7 | Topical Steroids | 34 | 0.9, 1.0 | 13.1, 14.7 |
Patient 14 (63/M/OS) | 17 | Anterior Uveitis (Posner-Schlossman Syndrome) | 0.7, 0.1 | 14.3, 38.3 | Topical Steroids IOP-lowering medication, | 65 | 0.8, 0.6 | 15.4, 16.4 |
Patient 15 (35/F/OU) | 12 | Intermediate Uveitis | 0.9, 0.9 | 17.7, 18.6 | Topical Steroids Peribulbar methylprednisolone injection Oral Ciclosporin Subcutaneous Injection of Adalimumab | 64 | 1.0, 1.0 | 12.4, 16.4 |
Patient 16 (24/F/OU) | 14 | Panuveitis | 0.1, 0.3 | 11.5, 16.5 | Topical Steroids Subconjunctival injection of dexamethasone Oral Steroids Mycophenolate Mofetil Subcutaneous Injection of Adalimumab | 55 | 0.2, 0.6 | 14.4, 13.5 |
Pediatric patient | ||||||||
Patient 17 (11/M/OU) | 7 | Anterior Uveitis (Juvenile Idiopathic Arthritis-associated Uveitis) | 1.2, LP | 14.1, 38.3 | Topical Steroids Oral Steroids Mycophenolate Mofetil Subcutaneous Injection of Adalimumab Peripheral Iridectomy | 92 | 1.2, LP | 13.3, 20.8 |
Patient 18 (12/F/OU) | 21 | Intermediate Uveitis | 0.7, 0.7 | 13.7, 16.5 | Topical Steroids Peribulbar methylprednisolone injection Oral Mycophenolate Mofetil Subcutaneous Injection of Adalimumab | 92 | 1.0, 1.2 | 14.4, 13.1 |